
Berkley Renewables Inc. Stock Analysis BKS.CN
Berkley Renewables, Inc. engages in the development and management of Solar PV projects in Ontario. The company is headquartered in Vancouver, British Columbia. The firm is pursuing solar energy investments in Ontario, Canada. The company is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The firm's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The firm is also developing a proprietary injection device (RCI) for optimal clinical delivery. The firm is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Read More Berkley Renewables Inc (BKS.CN) Chart
Financial Metrics & Statements of Berkley Renewables Inc (BKS.CN)
FAQ's for Berkley Renewables Inc (BKS.CN)
- According to Musaffa’s Shariah screening methodology, Berkley Renewables Inc (BKS.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.